Study of the Orsiro Drug Eluting Stent System

NAUnknownINTERVENTIONAL
Enrollment

452

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

December 31, 2018

Conditions
Coronary Artery Disease
Interventions
DEVICE

Percutaneous Coronary Intervention (Abbott Laboratories - Xience Prime DES)

Stenting

DEVICE

Percutaneous Coronary Intervention (Orsiro DES)

stenting

Trial Locations (24)

1002

Pauls Stradins Clinical University Hospital, Riga

1091

OLVG (Onze Lieve Vrouwe Gasthuis), Amsterdam

1122

Heart centre Semmelweis University, Budapest

1211

University Hospital of Geneva, Geneva

1708

University Hospital of Fribourg, Fribourg

3010

University Hospital of Bern (Inselspital), Bern

4600

Klinikum Wels-Grieskirchen, Wels

6000

Cantone Hospital of Lucerne, Lucerne

6900

Cardiocentro Ticino, Lugano

10117

Charité Campus Mitte, Berlin

12203

Charité Campus Benjamin Franklin, Berlin

18057

Universityhospital Rostock, Rostock

23538

Universityhospital Lübeck, Lübeck

23795

Segeberger Kliniken GmbH, Bad Segeberg

28222

Hospital Universitario Puerta de Hierro de Majadahonda, Madrid

32545

Heart- and Diabetescentre NRW, Bad Oeyenhausen

34295

CHU - Hospital Arnaud de Villeneuve, Montpellier

41007

Hospital Universitario Virgen de la Macarena, Seville

41464

Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss

79189

Heart Centre Bad Krozingen, Bad Krozingen

83192

Polyclinique les Fleurs Ollioules, Ollioules

90471

Klinikum Nuernberg Sued, Nuremberg

91300

Hospital Prive Jacques Cartier Massy, Massy

08036

Hospital Clínico y Provincial de Barcelona, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biotronik AG

INDUSTRY